Fiche centre
Investigational Site Number : 4100002
Seoul — South Korea
Essais liés3clinical trials
VilleSeoullocalisation
PaysSouth Korealocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06141486
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Frexalimab | SEP | Phase 3 | NCT06141486 | FREVIVA — Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| SAR442257 | Cancer | Phase 1 | NCT04401020 | First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL | TERMINATED |
| Tolebrutinib | SEP | Phase 3 | NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING |